Meyer Colin John Insider Trades

Insider Trading History

Track insider trading activity for Meyer Colin John. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $0 0 shares
Last Trade
Sep 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$97.5M 565,862 shares
$172.36
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $14.1M 81,633 shares
Last Trade
Aug 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$101k 596 shares
$168.74
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $14.2M 82,229 shares
Last Trade
Aug 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$362k 2,144 shares
$169.07
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $14.5M 84,373 shares
Last Trade
Jul 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$647k 6,000 shares
$107.89
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $13.5M 78,373 shares
Last Trade
May 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$50.6k 625 shares
$80.94
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $13.8M 80,137 shares
Last Trade
May 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$477k 5,608 shares
$84.97
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $14.6M 84,606 shares
Last Trade
Mar 07, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$52.5k 621 shares
$84.57
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $14.7M 85,227 shares
Last Trade
Mar 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$462k 5,286 shares
$87.35
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $30.9M 179,149 shares
Last Trade
Mar 02, 2023 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$7.69M 88,636 shares
$86.81
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.69M 88,636 shares
$86.81
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $12.8M 74,304 shares
Last Trade
Mar 02, 2023 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$7.69M 88,636 shares
$86.81
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $27M 156,397 shares
Last Trade
Mar 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.68M 88,636 shares
$86.69
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $28.1M 162,940 shares
Last Trade
Mar 02, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.69M 88,636 shares
$86.81
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $15.6M 90,513 shares
Last Trade
Feb 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 45,000 shares
$31.17
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Innovation Officer
Holding Value $16.5M 95,475 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.37M 118,988 shares
$36.71
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Research Officer
Holding Value $12.1M 70,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.87M 105,000 shares
$27.32
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Research Officer
Holding Value $12.8M 74,304 shares
Last Trade
Jun 16, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.79M 19,525 shares
$142.67
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Research Officer
Holding Value $0 0 shares
Last Trade
Jun 16, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.79M 19,525 shares
$142.67
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Research Officer
Holding Value $9.17M 53,186 shares
Last Trade
Jun 15, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.67M 40,000 shares
$141.85
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Research Officer
Holding Value $9.44M 54,779 shares
Last Trade
Jun 14, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$717k 5,000 shares
$143.42
$172.36

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up